Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era-Reference-Cited by-同舟云学术

Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era

Published:2004-05 Issue: Volume:28 Page:21-28
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Van Etten Richard A

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference63 articles.

1. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro;Van Etten;Oncogene,1995

2. An intramolecular SH3-domain interaction regulates c-Abl activity;Barila;Nat. Genet.,1998

3. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain;Brasher;Oncogene,2001

4. c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines;Brasher;J. Biol. Chem.,2000

5. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF;Plattner;Genes Dev.,1999

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N6-methyladenosine (m6A) RNA modification in chronic myeloid leukemia: unveiling a novel therapeutic target;Cellular and Molecular Life Sciences;2024-07-31

2. The Yin-Yang of myeloid cells in the leukemic microenvironment: Immunological role and clinical implications;Frontiers in Immunology;2022-12-01

3. Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia;Cancers;2021-05-12

4. Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML);European Journal of Pharmacology;2021-04

5. Philadelphia chromosome positive chronic myeloid leukemia with 5q deletion at diagnosis;Molecular Cytogenetics;2021-03-08